Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

Clinical trial NCT01356290 · RECRUITING

Trial details

NCT number: NCT01356290
Sponsor: Medical University of Vienna
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Medulloblastoma Recurrent Ependymoma Recurrent ATRT Recurrent Rare CNS Tumor Recurrent

Start date: 2014-04-01
Primary completion: 2030-04-01
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.